Menu
Back to User profile » Dr Suayib Yalcin
Papers published by Dr Suayib Yalcin:
A Post-International Gastrointestinal Cancers’ Conference (IGICC) Position Statements
Yalcin S, Lacin S, Kaseb AO, Peynircioğlu B, Cantasdemir M, Çil BE, Hurmuz P, Doğrul AB, Bozkurt MF, Abali H, Akhan O, Şimşek H, Sahin B, Aykan FN, Yücel İ, Tellioğlu G, Selçukbiricik F, Philip PA
Journal of Hepatocellular Carcinoma 2024, 11:953-974
Published Date: 29 May 2024
Recent Advances in Systemic Treatments for HER-2 Positive Advanced Gastric Cancer
Kahraman S, Yalcin S
OncoTargets and Therapy 2021, 14:4149-4162
Published Date: 13 July 2021
Prognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study
Lacin S, Yalcin S, Karakas Y, Hassan MM, Amin H, Mohamed YI, Rashid A, Morris JS, Xiao L, Qayyum A, Kaseb AO
Journal of Hepatocellular Carcinoma 2020, 7:143-153
Published Date: 16 September 2020
Impact of tivozanib on patient outcomes in treatment of advanced renal cell carcinoma
Yalcin S, Lacin S
Cancer Management and Research 2019, 11:7779-7785
Published Date: 16 August 2019
A national, multicenter, non-interventional, observational study on treatment patterns in patients with metastatic renal cell carcinoma in Turkey – NOTES study
Yalcin Ş, Yildiz R, Dane F, Karaoğlu A, Öksüzoğlu B, Özyilkan Ö, Sevinç A, Özdemir F, Turna H, Uslu R, Ulay E
OncoTargets and Therapy 2018, 11:1223-1228
Published Date: 5 March 2018
Evaluation of c-Met, HGF, and HER-2 expressions in gastric carcinoma and their association with other clinicopathological factors
Yıldız Y, Sokmensuer C, Yalcin S
OncoTargets and Therapy 2016, 9:5809-5817
Published Date: 22 September 2016
A case of acanthosis nigricans as a paraneoplastic syndrome with squamous cell lung cancer
Karakas Y, Esin E, Lacin S, Ceyhan K, Heper AO, Yalcin S
OncoTargets and Therapy 2016, 9:4815-4820
Published Date: 3 August 2016
Metastatic medullary thyroid cancer: a dramatic response to a systemic chemotherapy (temozolomide and capecitabine) regimen
Lacin S, Esin E, Karakas Y, Yalcin S
OncoTargets and Therapy 2015, 8:1039-1042
Published Date: 13 May 2015
Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population
Benekli M, Yalcin S, Ozkan M, Elkiran ET, Sevinc A, Cabuk D, Coskun HS, Oksuzoglu B, Bayar B, Akbulat A, Ozet A
OncoTargets and Therapy 2015, 8:1-5
Published Date: 15 December 2014
Neuropathic cancer pain: What we are dealing with? How to manage it?
Esin E, Yalcin S
OncoTargets and Therapy 2014, 7:599-618
Published Date: 17 April 2014
A review of the use of somatostatin analogs in oncology
Keskin O, Yalcin S
OncoTargets and Therapy 2013, 6:471-483
Published Date: 26 April 2013